Deals

Abogen Biosciences Strikes Licensing and Option Deal with Novartis for ABO2203 – Up to $7.2 Billion to Advance the First mRNA‑Encoded T‑Cell Engager in Autoimmune Disease
Abogen BiosciencesmRNA

Abogen Biosciences Strikes Licensing and Option Deal with Novartis for ABO2203 – Up to $7.2 Billion to Advance the First mRNA‑Encoded T‑Cell Engager in Autoimmune Disease

Abogen Biosciences Co., Ltd. ("Abogen"), a clinical‑stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agreement with Novartis AG (NYSE: NVS) to advance…

Dizal Receives $600 Million Upfront Payment from AstraZeneca as Global Sunvozertinib License Takes Effect – Only Dual‑Approved Oral TKI for EGFR Exon20ins NSCLC

Dizal Receives $600 Million Upfront Payment from AstraZeneca as Global Sunvozertinib License Takes Effect – Only Dual‑Approved Oral TKI for EGFR Exon20ins NSCLC

Henlius Forms Strategic Partnership with Zhejiang Cancer Hospital to Advance High‑Quality Oncology Care in China

Henlius Forms Strategic Partnership with Zhejiang Cancer Hospital to Advance High‑Quality Oncology Care in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Eli Lilly to Acquire Scorpion Therapeutics' STX-478 for $2.5B
Eli LillyNYSE: LLY

Eli Lilly to Acquire Scorpion Therapeutics’ STX-478 for $2.5B

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B
BiotechIntra-Cellular Therapies

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B

GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline
GlaxoSmithKlineGSK

GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline

Autobio Diagnostics Partners with Boditech Med for Korean IVD Market
Autobio DiagnosticsBoditech Med

Autobio Diagnostics Partners with Boditech Med for Korean IVD Market

Show More